News from the BioRegion STERN

Here you'll find all press releases and news from companies and institutes in the STERN BioRegion.

engl BioRegioSTERN-Portra~te-Widmann-Mauz.jpg

Whether you’re in a shark tank or the shower – optimism is a duty

BioGrafie: (Stuttgart/Tübingen) – Annette Widmann-Mauz used to be Member of the Bundestag (Germany’s Parliament) for Tübingen and part of the Christian Democrat Union (CDU) parliamentary group. She wa...
06/24/2025 | CureVac AG

CureVac Announces Voting Results of General Meeting

CureVac N.V. (Nasdaq: CVAC), a pioneering multinational biotech company developing a new class of transformative medicines based on messenger RNA (mRNA), today announced the voting results of the Comp...
06/12/2025 | CureVac AG

BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer

Acquisition will strengthen the research, development, manufacturing and commercialization of mRNA-based cancer immunotherapy candidates, marking BioNTech’s next key mile...
ZIM Innovationstag BRS(6).png

Two Inspiring Days Dedicated to Innovation – Experience Exchange for ZIM Network Managers and Innovation Day for SMEs 2025

On June 4 and 5, 2025, we had the opportunity to participate in two outstanding events that focused on the innovative SME sector in Germany and highlighted the central ro...
Teaserbild Oralgenix PI.png

In everyone’s mouth: Early identification of a widespread disease –periodontitis

(Stuttgart/Reutlingen) – Dr. Severino Urban and Dr. Stefan Frey founded Oralgenix GmbH in Reutlingen Technology Park in 2025. Using molecular biological analyses of the m...

Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma

Stafford, Texas and Tuebingen, Germany, May 31, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the...
05/15/2025 | CureVac AG

CureVac Receives Additional Positive Validity Decision from European Patent Office in Ongoing Litigation Against BioNTech SE

TÜBINGEN, Germany/BOSTON, USA –  May 15, 2025CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biotech company developing a new class of transformative medicines based on...

Immatics Announces First Quarter 2025 Financial Results and Business Update

Houston, Texas and Tuebingen, Germany, May 13, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company active in the ...
WhatsApp-Image-2025-05-14-at-09.51.11-1024x752.jpeg
05/13/2025 | Council of European BioRegions (CEBR)

The Council of European BioRegions Announces - New Board for 2025 - 2026

The Council of European BioRegions (CEBR), the leading network of life science clusters across Europe, is pleased to announce the results of its 2025–2026 Board Elections...
090525_Hospitalhof_BioRegioStern_16.jpg
05/12/2025 | BioRegio STERN Management GmbH BIOPRO Baden-Württemberg GmbH AHP International & Economic Development Partnership of North Carolina

Transatlantic Bridge-Building in the Life Sciences Sector

On May 9, 2025, representatives from the life sciences industry in North Carolina and Baden-Württemberg met in Stuttgart for professional exchange. The goal of the event was to explore opportunities f...
pm-13-25-SimBioZe-universitaet-stuttgart-ILEK-Biobetonprobe.jpg

Bio-concrete from urine

Researchers at the University of Stuttgart have used microbial processes to produce environmentally friendly bio-concrete from urine as part of a “wastewater-bio-concrete-fertilizer” value chain. With the project extension granted by the Baden-W...
04/15/2025 | HepaRegeniX GmbH

HepaRegeniX completes €21.5 million financing to support clinical advancement of HRX-215 for liver regeneration

Tuebingen, Germany, April 15, 2025 – HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver diseases, today...
Innovationscommunity _DIIC.JPEG

In future, the operating theatre will be part of the team

(Stuttgart/Reutlingen) – The “Digital Integration and Innovation in Surgery” (Digitale Integration und Innovation in der Chirurgie, DIIC) project aims to promote the transfer of new findings and resea...
04_04_25BIORegioS17.jpg

Review: Seminar on the Reimbursement Eligibility of Medical Devices and Diagnostics in Stuttgart

On April 4, 2025, BioRegio STERN Management GmbH, together with VOELKER & Partner Attorneys, Auditors, and Tax Advisors mbB, hosted an interactive seminar in Stuttgar...
03/28/2025 | CureVac AG

CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE

CureVac N.V. (Nasdaq: CVAC) (“CureVac”), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”...
engl-A-25_02_25Step4N04.jpg

Working together to set the stage for NAMs in the development of drugs and medical devices

(Stuttgart) – BioRegio STERN Management GmbH is the lead partner responsible for the new STEP4NAMs project (Step up the use for new approach methodologies to replace anim...
csm_20250306_Zirkulierende_Tumorzellen_PM_2_Abbildung_Hans_Neubauer_Universitaet-Frauenklinik_Duesseldorf_503d686df2.jpg

NMI TT in Reutlingen and Düsseldorf University Women's Hospital develop high-precision method for analyzing individual circulating tumor cells

Researchers led by Dr. Michael Pawlak from NMI Technologie Transfer GmbH (NMI TT) in Reutlingen and Prof. Dr. Hans Neubauer from the Women's Hospital at the University of...
A-25_02_25Step4N08.jpg

Kick-off Meeting of STEP4NAMs: Shaping the Future of NAMs Together

On February 25 and 26, 2024, the official kick-off meeting of the STEP4NAMs project took place in Stuttgart. Our international consortium of ten partners gathered to set the course for promoting New A...
engl Michael Kaiser-k2.jpg

WRS Managing Director Michael Kaiser elected as new Chair

(Stuttgart/Reutlingen) – Michael Kaiser, Managing Director of Wirtschaftsförderung Region Stuttgart GmbH (WRS), was unanimously elected the new Chair of the Supervisory Board of BioRegio STERN Managem...
[DE Copy] Gruppenbild NAMWISE Kickoff

New methods for reliable evaluation of chemicals and pharmaceuticals

(Stuttgart) – BioRegio STERN Management GmbH is a German partner in the European NAMWISE (New Approach Methodologies Within Integrated Safety & Efficacy evaluation of chemicals and pharmaceuticals...